Literature DB >> 16552255

Medication adherence in glaucoma: approaches for optimizing patient compliance.

James C Tsai1.   

Abstract

PURPOSE OF REVIEW: To summarize recent literature regarding medication adherence with a focus on the complexities inherent in glaucoma management. RECENT
FINDINGS: Adherence to medications can be enhanced by undertaking the following strategies: enhanced patient education; improved dosing schedules; increased accessibility to healthcare (including longer hours, evening hours, and shorter wait times), and improved provider-patient relationships (e.g. increased trust). Patients may be less likely to forgo medication use due to cost pressures if the physician trust level is high. Recent studies suggest a role for baseline screening for adherence predictors and focused interventions in addressing modifiable risk factors for poor adherence (such as depression, stress, and lower education).
SUMMARY: Many factors are associated with the lack of medication adherence in patients. The solution is likely to be multi-dimensional and employ combination strategy (must be individualized for the patient). Educational interventions involving patients, family members, or both can be effective in improving adherence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552255     DOI: 10.1097/01.icu.0000193078.47616.aa

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  30 in total

1.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

2.  [Preservative-containing eye drops and adherence in ophthalmological practice].

Authors:  I Lanzl; T Kaercher
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

3.  Determinants of medication adherence to topical glaucoma therapy.

Authors:  Laura E Dreer; Christopher Girkin; Steven L Mansberger
Journal:  J Glaucoma       Date:  2012 Apr-May       Impact factor: 2.503

4.  Electronic compliance monitoring of topical treatment after ophthalmic surgery.

Authors:  Manuel Marcel Hermann; Can Ustündag; Michael Diestelhorst
Journal:  Int Ophthalmol       Date:  2010-04-07       Impact factor: 2.031

Review 5.  Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.

Authors:  David C Broadway; Heidi Cate
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

6.  Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.

Authors:  Joshua D Stein; David D Kim; Will W Peck; Steven M Giannetti; David W Hutton
Journal:  Arch Ophthalmol       Date:  2012-02-13

7.  Improvement in outflow facility by two novel microinvasive glaucoma surgery implants.

Authors:  Cassandra L Hays; Vikas Gulati; Shan Fan; Thomas W Samuelson; Iqbal Ike K Ahmed; Carol B Toris
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-28       Impact factor: 4.799

8.  In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.

Authors:  Joseph B Ciolino; Cristina F Stefanescu; Amy E Ross; Borja Salvador-Culla; Priscila Cortez; Eden M Ford; Kate A Wymbs; Sarah L Sprague; Daniel R Mascoop; Shireen S Rudina; Sunia A Trauger; Fabiano Cade; Daniel S Kohane
Journal:  Biomaterials       Date:  2013-10-04       Impact factor: 12.479

9.  A drug-eluting contact lens.

Authors:  Joseph B Ciolino; Todd R Hoare; Naomi G Iwata; Irmgard Behlau; Claes H Dohlman; Robert Langer; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

10.  An exploratory study of factors influencing glaucoma treatment adherence.

Authors:  Jo Ellen Stryker; Allen Dale Beck; Susan A Primo; Katharina V Echt; Lucja Bundy; Grace Cho Pretorius; Karen Glanz
Journal:  J Glaucoma       Date:  2010-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.